Total planned funding: $1,531,882,722
Allocations
Countries/Regions
South Africa | $255,662,547 |
Kenya | $241,469,185 |
Nigeria | $211,980,621 |
Tanzania | $150,297,413 |
Uganda | $125,662,795 |
Ethiopia | $117,538,288 |
Zambia | $109,046,223 |
Mozambique | $66,771,390 |
Rwanda | $52,542,920 |
Haiti | $51,569,108 |
Côte d'Ivoire | $46,128,109 |
Namibia | $31,074,465 |
Botswana | $25,426,148 |
Vietnam | $15,098,500 |
Zimbabwe | $8,652,500 |
Guyana | $8,021,435 |
Eswatini | $4,468,000 |
Malawi | $2,451,777 |
Democratic Republic of the Congo | $2,405,547 |
Lesotho | $1,365,000 |
Cambodia | $1,043,402 |
Dominican Republic | $747,882 |
India | $735,511 |
Ghana | $650,000 |
China | $622,900 |
Caribbean Region | $286,056 |
Indonesia | $165,000 |
Organizational Types
Unknown | $576,594,799 |
Private Contractor | $341,454,445 |
NGO | $234,339,425 |
University | $153,518,175 |
Implementing Agency | $106,756,589 |
FBO | $73,285,400 |
Host Country Government Agency | $35,940,230 |
Own Agency | $3,467,163 |
Multi-lateral Agency | $3,334,048 |
Parastatal | $2,971,368 |
Other USG Agency | $221,080 |
Program Areas
Treatment | $1,531,882,722 |
Budget Codes
HTXS: Treatment: Adult Treatment | $907,953,447 |
HTXD: Treatment: ARV Drugs | $519,288,148 |
PDTX: Treatment: Pediatric Treatment | $104,641,127 |